Investment in pneumonia and pneumococcal research

We had a comment piece published in Lancet Infectious Diseases in October 2014, briefly discussing the UK portfolio related to pneumonia. We highlight the relative paucity of funding available in this area, and also the predominance of pre-clinical science with little translational work completed or ongoing in pneumonia research.

See the comment piece on the Lancet ID website.

Tweet about this on TwitterShare on Google+Share on LinkedInShare on Facebook